Vascular Health and Risk Management

Editor in Chief Professor Roland Asmar

Editorial ||FREE PAPER||
Reza Tabrizchi

In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease
Rabea Asleh, Andrew P Levy

New anticoagulants for the prevention and treatment of venous thromboembolism
Simon J McRae, Jeffrey S Ginsberg

Opinion - Reducing cardiovascular risk: too little, too late, too short-term
David Gray

Opinion - Coxibs: can this class of drugs survive?
Reza Tabrizchi

Barriers to and strategies for effective blood pressure control
David Siegel

Cardiovascular risk assessment and management in developing countries
Shanthi Mendis

Ongoing clinical trials of the pleiotropic effects of statins
Jean Davignon, Lawrence A Leiter

Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium
Hong Ding, Chris R Triggle

Restenosis after percutaneous angioplasty: the role of vascular inflammation
Martin Schillinger, Erich Minar

Folic acid: a marker of endothelial function in type 2 diabetes?
Arduino A Mangoni, Roy A Sherwood, Belinda Asonganyi, Emma L Ouldred, Stephen Thomas, Stephen HD Jackson

Relationship between arterial stiffness and heart rate recovery in apparently healthy adults
Ding-Yu Fei, Ross Arena, James A Arrowood, Kenneth A Kraft

Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University